–
Inovio Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−301
FY22:
−268
FY23:
−144
FY24:
−112
FY25:
−86.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−293
FY22:
−263
FY23:
–
FY24:
−109
FY25:
−83.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−303
FY22:
−278
FY23:
−135
FY24:
−107
FY25:
−84.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−304
FY22:
−280
FY23:
−135
FY24:
−107
FY25:
−84.9
All amounts in millions USD